Molecular epidemiology of the human immunodeficiency virus tipe 1 in Santiago, Chile;Epidemiología molecular del virus de inmunodeficiencia humana tipo 1 en Santiago, Chile

Revista Medica de Chile

Volumn 127, Issue 11, 1999, Pages 1294-1304

  Pérez C, Carlos ^a,b   Vial C, Pablo ^a   Dorman, Karin S ^a   Wang, Greg ^a   Wang, Guangqiang ^a   Abarca V, Katia ^a   Sinsheimer, Janet S ^a   Kaplan, Andrew H ^a  

^a Pont Univ Católica de Chile ^*

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acquired immunodeficiency syndrome; AIDS serodiagnosis; HIV 1; Virology

Indexed keywords

PROTEINASE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHILE; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CHILE; DNA, VIRAL; FEMALE; HIV PROTEASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0033222378     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. HAHN BH, GONDA MA, SHAW GM, POPOVIC M, HOXIE JA, GALLO RC, WONG-STAAL F. Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci USA 1985; 82: 4813-7.
2. COFFIN JM. Genetic variation in AIDS viruses. Cell 1986; 46: 1-14.
3. STARCICH BR, HAHN BH, SHAW GM, MC NELLY PD, MODROW S, WOLF H ET AL. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986; 45: 637-48.
4. SIMMONDS P, BALFE P, LUDLAM CA, BISHOP JO, LEIGH BROWN AJ. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 1990; 64: 5840-50.
5. OU C-Y, CIESIELSKI CA, MYERS G, BANDEA CI, LUO CC, KORBER BT ET AL. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256: 1165-71.
6. JAFFE HW, MCCURDY JM, KALISH ML, LIBERTI T, METELLUS G, BOWMAN BH ET AL. Lack of HIV transmision in the practice of a dentist with AIDS. Ann Intern Med 1994; 121: 855-9.
7. HOLMES EC, ZHANG LQ, ROBERTSON P, CLELAND A, HARVEY E, SIMMONDS P, LEIGH BROWN AJ. The molecular epidemiology of human immunodeficiency virus type-1 in Edinburg. J Infect Dis 1995; 171: 45-53.
8. Community-level prevention of human immunodeficiency virus infection among high risk populations: The AIDS community demonstration projects. MMWR 1996; 45(RR-6): 1-16.
9. LOUSSERT-AJAKA I, LY TD, CHAIX ML, INGRAND D, SARAGOSTI S, COUROUCE AM ET AL. HIV-1/HIV-2 seronegativity in HIV-1 infected patients. Lancet 1994; 343: 1393-4.
10. SCHABLEE C, ZEKENG L, PAU CP, HU D, KAPTUE L, GURTLER L ET AL. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344: 1333-4.
11. WHO network for HIV isolation and characterization HIV type-1 variation in world health organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994; 10: 1327-43.
12. JAVAHERIAN K, LANGLOIS AJ, MCDANAL C, ROSS KL, ECKLER LI, JELLIS CL ET AL. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989; 86: 6708-72.
13. HWANG SS, BOYLE TJ, LYERLY HK, CULLEN BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991; 253: 71-4.
14. GRIMAILA RJ, FULLER BA, RENNERT PD, NELSON MB, HAMMARSKJOLD ML, POTTS B ET AL. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 1992; 66: 1875-83.
15. Human retroviruses and AIDS 1998. Los Alamos National Laboratory, Los Alamos, New Mexico, 1998. (HIV sequence database. http://hiv-. web.lanl.gov/).
16. LOUWAGIE J, MCCUTCHAN FE, PEETERS M, BRENNAN TP, SANDERS-BUELL E, EDDY GA ET AL. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993; 7: 769-80.
17. LECH WJ, WANG G, YANG YL, CHEE Y, DORMAN K, MC CRAE D ET AL. In vivo sequence diversity of the protease of human immunodeficiency virus type-1: Presence of protease inhibitor resistance variants in untreated subjects. J Virol 1996; 70: 2038-43.
18. BARRIE KA, PÉREZ EE, LAMERS SL, FARMERIE WG, DUNN BM, SLEASMAN JW, GODENOW MM. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Virology 1996; 219: 407-16.
19. Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO). The AIDS epidemic update, December 1998.
20. WARDEN RQ, WONG MT, MELCHER GR, BLATT SP, CAHN P, PÉREZ H ET AL. Serologic evaluation of human immunodeficiency virus type-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. J Clin Microbiol 1995; 33: 481-3.
21. CABELLO A, CABRAL M, VERA ME, KIEFER R, AZORERO RM, EBERLE J ET AL. Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay. Aids Res Hum Retroviruses 1995; 11: 1135-7.
22. QUIÑONES-MATEU ME, DOPAZO J, ESTE JA, ROTA TR, DOMINGO E. Molecular characterization of human immunodeficiency virus type-1 isolates from Venezuela. AIDS Res Hum Retroviruses 1995; 11: 605-16.
23. LOUWAGIE J, DELWART EL, MULLINS JI, MCCUTCHAN FE, EDDY G, BURKE DS. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses 1994; 10: 561-7.
24. RAMOS A, TANURI A, SCHECHTER M, RAYFIELD MA, HU DJ, CABRAL MC ET AL. Dual and recombinant infections: An integral part of the HIV-1 epidemic in Brazil. Emerg Infect Dis 1999; 5: 65-74.
25. ARTENSTEIN AW, COPPOLA J, BROWN AE, CARR JK, SANDERS-BUELL E, GALBARINI E ET AL. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet 1995; 346: 1197-8.
26. FIGUEROA F, PALACIOS A, RIVERO S, ODDÓ D, ROA I, HONEYMAN J ET AL. Chronic diarrhea due to Isospora belli and Kaposi's Sarcoma in a male homosexual. Report of the 1st case of acquired immunodeficiency syndrome in Chile. Rev Med Chile 1985; 113: 772-9.
27. Boletín Epidemiológico CONASIDA. Marzo de 1999. Ministerio de Salud de Chile.
28. DESGRANGES C, FILLON S, LETOURNEUR F, BUZELAY L, SEPÚLVEDA C, GUZMÁN MA ET AL. HIV-1 subtypes in Santiago, Chile (letter). AIDS 1998; 12: 1503-5.
29. DELWART EL, SHPAER EG, LOUWAGIE J, MC CUTCHAN FE, GREZ M, RUBSAMENT-WAIGMAN H, MULLINS JI. Genetic relationship determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993; 262: 1257-61.
30. FELSENSTEIN J. PHYLIP (phylogeny inference package) version 3,5. 1993. Department of Genetics. University of Washington, Seattle.
31. KIMURA M. A simple method for estimating the evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-20.
32. SAITOU N, NEI M. The neighbor joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-25.
33. CONDRA JH, SCHLEIF WA, BLAHY OM, GABRYELSKI LJ, GRAHAM DJ, QUINTERO JC ET AL. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (London) 1995; 374: 569-71.
34. HO DD, TOYOSHIMA T, MO H, KEMPF, NORBECK D, CHEN CM ET AL. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J Virol 1994; 68: 2016-20.13-
35. KAPLAN AH, MICHAEL SF, WEHBIE RS, KNIGGE MF, PAUL DA, EVERITT L, KEMPF DJ, NORBECK DW, ERICKSON J, SWANSTROM R. Selection of multiple HIV-1 variants with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci (USA) 1994; 91: 5597-601.
36. OTTO MJ, GARBER S, WINSLOW DL, REID CD, ALDRICH P, JADHAV PK, PATTERSON CE, HODGE CN, CHENG YS. In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc Natl Acad Sci (USA) 1993; 90: 7543-7.
37. POTTS KE, KALISH ML, LOTT T, ORLOFF G, LUO CC, NERNARD MA ET AL. Genetic heterogeneity of the V3 region of the HIV-1 envelope plycoprotein in Brazil. AIDS 1993; 7: 1191-7.
38. LI Y, LUO L, RASOOL N, KANG CY. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4. J Virol 1993; 67: 584-8.
39. MOHRI H, SINGH MK, CHING WT, DD HO. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proc Natl Acad Sci (USA) 1993; 90: 25-9.